LADTX | Developing Growth Fund Class R5 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Developing Growth Fund

Summary

Summary

What is the Developing Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

 

Fund Basicsas of 12/31/2021

Total Net Assets
$4.46 B
Inception Date
06/30/2015
Dividend Frequency
Annually
Fund Expense Ratio
0.68%
Number of Holdings
95

Fund Expense Ratio :

0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -2.41% -2.41% 30.71% 25.10% 17.32% -
Lipper Category Avg. Small-Cap Growth Funds 11.32% 11.32% 24.93% 17.46% 14.91% -
Russell 2000® Growth Index 2.83% 2.83% 21.17% 14.53% 14.14% -

Fund Expense Ratio :

0.68%

Fund Expense Ratio :

0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -2.41% -2.41% 30.71% 25.10% 17.32% -
Lipper Category Avg. Small-Cap Growth Funds 11.32% 11.32% 24.93% 17.46% 14.91% -
Russell 2000® Growth Index 2.83% 2.83% 21.17% 14.53% 14.14% -

Fund Expense Ratio :

0.68%

TEN LARGEST HOLDINGS as of 12/31/2021View Portfolio

Holding Assets
Calix Inc 3.1%
Crocs Inc 2.4%
Endava PLC 2.4%
Diodes Inc 2.3%
Semtech Corp 2.2%
Ambarella Inc 1.9%
SiTime Corp 1.9%
Tempur Sealy International Inc 1.9%
Rapid7 Inc 1.8%
Shockwave Medical Inc 1.8%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

34 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

20 Years of Industry Experience

Benjamin Ebel
Benjamin Ebel

Portfolio Manager

29 Years of Industry Experience

Supported By 6 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -2.41% -2.41% 30.71% 25.10% 17.32% -
Lipper Category Avg. Small-Cap Growth Funds 11.32% 11.32% 24.93% 17.46% 14.91% -
Russell 2000® Growth Index 2.83% 2.83% 21.17% 14.53% 14.14% -

Fund Expense Ratio :

0.68%

Fund Expense Ratio :

0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -2.41% -2.41% 30.71% 25.10% 17.32% -
Lipper Category Avg. Small-Cap Growth Funds 11.32% 11.32% 24.93% 17.46% 14.91% -
Russell 2000® Growth Index 2.83% 2.83% 21.17% 14.53% 14.14% -

Fund Expense Ratio :

0.68%

Year Fund Returns Russell 2000® Growth Index
2021 -2.41% 2.83%
2020 72.95% 34.63%
2019 32.31% 28.48%
2018 5.32% -9.31%
2017 30.27% 22.17%
2016 -2.48% 11.32%
2015 -8.64% -1.38%
2014 3.56% 5.60%
2013 57.77% 43.30%
2012 10.73% 14.59%
2011 -1.30% -
2010 37.01% -
2009 47.54% -
2008 -47.31% -
2007 36.29% -
2006 12.86% -
2005 12.31% -
2004 6.39% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2021 1.72% 2.93% -3.63% -3.28% -2.41%
2020 -16.93% 40.77% 15.98% 27.53% 72.95%
2019 27.10% 9.18% -11.29% 7.48% 32.31%
2018 7.20% 15.07% 12.22% -23.91% 5.32%
2017 8.45% 4.10% 7.14% 7.71% 30.27%
2016 -10.24% 2.28% 10.94% -4.25% -2.48%
2015 7.18% 2.69% -15.63% -1.62% -8.64%
2014 1.76% 0.24% -5.71% 7.66% 3.56%
2013 13.60% 10.13% 18.88% 6.09% 57.77%
2012 12.24% -2.59% 5.66% -4.16% 10.73%
2011 10.32% 1.61% -20.78% 11.16% -1.30%
2010 8.25% -7.85% 16.61% 17.79% 37.01%
2009 -2.06% 24.50% 14.24% 5.91% 47.54%
2008 -21.75% 6.69% -11.69% -28.53% -47.31%
2007 4.75% 13.67% 9.96% 4.10% 36.29%
2006 16.07% -6.14% -6.74% 11.08% 12.86%
2005 -5.76% 5.86% 9.71% 2.62% 12.31%
2004 - - - 11.64% 6.39%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 9/30/2021

  • Unlike 2020, this year continues to be a challenging environment to identify market leadership, as the Delta variant of Covid-19 has somewhat slowed what was a vibrant economic re-opening and shifted leadership back towards some secular growth stocks; however, these shifts have been uneven, as earnings results have also been highly consequential.  Companies beating expectations by a substantial amount have fared well, while those that have missed on key metrics have been punished harshly, and we anticipate markets will see continued volatility as uncertainty about economic activity and inflation persists. In months where earnings data is light, short-term macro data and central bank comments are causing big reactions in the market, both positive and negative, as speculation mounts over the pace and timing of asset purchase tapering by the Federal Reserve.
  • In the small cap asset class, we are seeing valuations today continue to trade at a discount to large caps, a historical anomaly, as investors have overwhelmingly favored cash-rich, dominant, enormously profitable companies during this period of uncertainty, even if their growth is slowing.  We anticipate a reversion to small caps over the next few years, with innovation leading, but it may take time for the preference for mega cap stocks to unwind.
  • Our active approach continues to focus on identifying high innovation companies with both operating momentum and price momentum, and it is through this lens that we continuously assess our portfolio and developments in the broader economy.

Portfolio Details as of 12/31/2021

Total Net Assets
$4.46 B
Number of Holdings
95
Weighted Average Market Cap.
6.1 B
P/B Ratio
6.9x
P/E Ratio
26.7x

Contributors & Detractors as of  12/31/2021

Contributors

Holding Contribution
Calix Inc 1.1%
Intra-Cellular Therapies Inc 0.5%
Sitime Corporation 0.4%
Endava Plc 0.4%
Ambarella, Inc. 0.4%

Detractors

Holding Contribution
Bridgebio Pharma Inc -0.5%
Asana Inc -0.5%
Sprout Social Inc -0.5%
Bumble Inc -0.4%
Alx Oncology Hldgs Inc -0.4%

Attribution Analysis 

Developing Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Upcoming Dividend Payment Dates

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/21/2022 11/22/2022 11/22/2022

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $3.3406 - $3.3406 $36.00

Upcoming Capital Gain Distribution

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/21/2022 11/22/2022

Fees & Expenses

Fees & Expenses

Expense Ratioas of 12/31/2021

0.68%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2000® Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field